AU676166B2 - Immediate early HSV-2 viral protein ICP27 as vaccine - Google Patents
Immediate early HSV-2 viral protein ICP27 as vaccine Download PDFInfo
- Publication number
- AU676166B2 AU676166B2 AU43264/93A AU4326493A AU676166B2 AU 676166 B2 AU676166 B2 AU 676166B2 AU 43264/93 A AU43264/93 A AU 43264/93A AU 4326493 A AU4326493 A AU 4326493A AU 676166 B2 AU676166 B2 AU 676166B2
- Authority
- AU
- Australia
- Prior art keywords
- hsv
- protein
- icp27
- ctl
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9213559 | 1992-06-25 | ||
GB9213559A GB9213559D0 (en) | 1992-06-25 | 1992-06-25 | Vaccines |
PCT/EP1993/001525 WO1994000575A1 (en) | 1992-06-25 | 1993-06-15 | Immediate early hsv-2 viral protein icp27 as vaccine |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17855/97A Division AU1785597A (en) | 1992-06-25 | 1997-04-14 | Immediate early HSV-2 viral protein ICP27 as vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4326493A AU4326493A (en) | 1994-01-24 |
AU676166B2 true AU676166B2 (en) | 1997-03-06 |
Family
ID=10717757
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43264/93A Ceased AU676166B2 (en) | 1992-06-25 | 1993-06-15 | Immediate early HSV-2 viral protein ICP27 as vaccine |
AU17855/97A Abandoned AU1785597A (en) | 1992-06-25 | 1997-04-14 | Immediate early HSV-2 viral protein ICP27 as vaccine |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17855/97A Abandoned AU1785597A (en) | 1992-06-25 | 1997-04-14 | Immediate early HSV-2 viral protein ICP27 as vaccine |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0649470A1 (es) |
JP (1) | JPH07508648A (es) |
KR (1) | KR950702244A (es) |
CN (1) | CN1092812A (es) |
AU (2) | AU676166B2 (es) |
CA (1) | CA2138996A1 (es) |
GB (1) | GB9213559D0 (es) |
MX (1) | MX9303771A (es) |
NZ (1) | NZ253138A (es) |
TW (1) | TW269635B (es) |
WO (1) | WO1994000575A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1659178T1 (sl) * | 1998-02-05 | 2010-07-30 | Glaxosmithkline Biolog Sa | Postopek za čiščenje ali proizvodnjo MAGE proteina |
DK1092779T3 (da) * | 1999-10-11 | 2010-02-15 | Pasteur Institut | Lentiviirusvektorer til fremstilling af immunterapeutiske præparater |
US7196066B1 (en) | 1999-11-03 | 2007-03-27 | Powderject Vaccines, Inc. | DNA-vaccines based on constructs derived from the genomes of human and animal pathogens |
JP2007505147A (ja) * | 2003-09-12 | 2007-03-08 | アンティジェニクス インコーポレーテッド | 単純ヘルペスウイルス感染の治療および予防用ワクチン |
-
1992
- 1992-06-25 GB GB9213559A patent/GB9213559D0/en active Pending
-
1993
- 1993-06-15 WO PCT/EP1993/001525 patent/WO1994000575A1/en not_active Application Discontinuation
- 1993-06-15 AU AU43264/93A patent/AU676166B2/en not_active Ceased
- 1993-06-15 NZ NZ253138A patent/NZ253138A/en unknown
- 1993-06-15 CA CA 2138996 patent/CA2138996A1/en not_active Abandoned
- 1993-06-15 EP EP19930912991 patent/EP0649470A1/en not_active Withdrawn
- 1993-06-15 JP JP6502006A patent/JPH07508648A/ja active Pending
- 1993-06-23 MX MX9303771A patent/MX9303771A/es unknown
- 1993-06-24 CN CN93109561A patent/CN1092812A/zh active Pending
- 1993-09-01 TW TW82107123A patent/TW269635B/zh not_active IP Right Cessation
-
1994
- 1994-12-24 KR KR1019940704739A patent/KR950702244A/ko not_active Application Discontinuation
-
1997
- 1997-04-14 AU AU17855/97A patent/AU1785597A/en not_active Abandoned
Non-Patent Citations (2)
Title |
---|
MCGEOCH D J ET AL (1991) JOURNAL OF GENERAL VIROLOGY * |
VOL 72, PAGES 3057-3075 * |
Also Published As
Publication number | Publication date |
---|---|
AU1785597A (en) | 1997-06-19 |
AU4326493A (en) | 1994-01-24 |
TW269635B (es) | 1996-02-01 |
MX9303771A (es) | 1994-05-31 |
CA2138996A1 (en) | 1994-01-06 |
GB9213559D0 (en) | 1992-08-12 |
NZ253138A (en) | 1995-10-26 |
CN1092812A (zh) | 1994-09-28 |
JPH07508648A (ja) | 1995-09-28 |
EP0649470A1 (en) | 1995-04-26 |
WO1994000575A1 (en) | 1994-01-06 |
KR950702244A (ko) | 1995-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040228842A1 (en) | Compositions and methods for cytomegalovirus treatment | |
JPH06506705A (ja) | 再発性hsv感染用の免疫療法 | |
EP2263686B1 (en) | Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments | |
KR20150014500A (ko) | Hsv-2 백신 | |
US20180207261A1 (en) | Human herpesvirus immunotherapy | |
NO20021479L (no) | Immunologiske signifikante herpes simplex virus antigener og metoder for å identifisere og å bruke dem | |
EP1047446B1 (en) | Vaccine composition for herpes simplex virus and methods of using | |
JP5845191B2 (ja) | 単純ヘルペスウイルスワクチン | |
JPH084508B2 (ja) | 組み換えワクチニアウイルス | |
WO1995016779A9 (en) | Herpes-symplex-virus type 2 icp4 protein and its use in a vaccine composition | |
JPH08508728A (ja) | パピローマウィルスに基づく医薬品 | |
CN111925994B (zh) | 一种dp71l基因缺失的重组非洲猪瘟病毒及其制备方法和应用 | |
US7638132B2 (en) | Highly safe smallpox vaccine virus and vaccinia virus vector | |
CA2086740A1 (en) | Equine herpesvirus-4 tk-vaccine | |
AU676166B2 (en) | Immediate early HSV-2 viral protein ICP27 as vaccine | |
Aravind et al. | Protective effects of recombinant glycoprotein D based prime boost approach against duck enteritis virus in mice model | |
CN114657154B (zh) | 一种羊传染性脓疱病毒减毒株的制备方法及其应用 | |
JP2023545524A (ja) | 組換えhvt及びその使用 | |
WO2006113927A2 (en) | Immunogenic vaccinia peptides and methods of using same | |
US10172933B2 (en) | Mosaic vaccines for serotype a foot-and-mouth disease virus | |
AU672870B2 (en) | Vaccines against varicella-zoster virus (VZV) | |
GB2062463A (en) | Babesiosis vaccine | |
CN1222393A (zh) | 疫苗组合物及其制备方法 | |
Zajac | Identification of African Swine Fever Virus antigens for development of an efficacious subunit vaccine | |
KR20230153047A (ko) | 톡소포자충의 항원 rop4를 포함하는 재조합 백시니아 바이러스 백신 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |